Evidence map›Paper›PMID 41859672›Full record

ArticleEClinicalMedicine2026

Corrigendum to 'Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial' eClinicalMedicine 2026; 92: 103764.

Michael R Lassen, Matthew Scarborough, Nigel Gilchrist, Shiva S Tripathi, Cathy Price, Angel Horcajadas, Javier DeAndres, Ganesan Baranidharan, Sashin Ahuja, Kristian S Otte and 5 more

Abstract readPublished Erratum
In one paragraph

Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Michael R LassenCapio Privathospital Hellerup, Tuborg Boulevard 1, 2900, Hellerup, Denmark.
Matthew ScarboroughBone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Windmill Road, Headington, Oxford, OX3 7HE, UK.
Nigel GilchristCGM Research Trust, Level 3, 800 Colombo Street, Christchurch Central City, Christchurch, 8013, New Zealand.
Shiva S TripathiNIHR Lancashire Clinical Research Facility, Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Ln, Fulwood, Preston, PR2 9HT, UK.
Cathy PriceHampshire and Isle of Wight Foundation Trust, Tatchbury Mount, Calmore, Southampton, SO40 2RZ, UK.
Angel HorcajadasHospital Vithas Granada, Avd. Valle de la Ballstera, 59, Granada, Spain.
Javier DeAndresThe Hospital Universitario La Paz, P.° de la Castellana, 261, Fuencarral-El Pardo, 28046, Madrid, Spain.
Ganesan BaranidharanThe Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF, UK.
Sashin AhujaUniversity Hospital of Wales, Cardiff and Vale University Health Board, Heath Park, Cardiff, CF14 4XW, UK.
Kristian S OtteCapio Privathospital Hellerup, Tuborg Boulevard 1, 2900, Hellerup, Denmark.
Emily WoodVeramed Ltd, 5th Floor Regal House, 70 London Road, Twickenham, TW1 3QS, UK.
Sarah GuestPersica Pharmaceuticals Limited, 7 Denne Hill Business Centre, Womenswold, Canterbury, Kent, CT4 6HD, UK.
Lloyd G CzaplewskiPersica Pharmaceuticals Limited, 7 Denne Hill Business Centre, Womenswold, Canterbury, Kent, CT4 6HD, UK.
Duncan McHalePersica Pharmaceuticals Limited, 7 Denne Hill Business Centre, Womenswold, Canterbury, Kent, CT4 6HD, UK.
Modic Trial (TMT) group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.eclinm.2026.103764.].

Identifiers

PMID41859672
PMCPMC12996226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.